$ALHC

3 theses

bullish 33%neutral 0%bearish 67%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 2, 4:15 PM ET

$ALHCSEC Form 4bearish

Kim Hyong · Chief Medical Officer at Alignment Healthcare, Inc. · 26d agono track record yet

Sold 32,479 @ $8.30 avg · $269,576 · 2026-10-06

Form 4: Kim Hyong sold ALHC

Kim Hyong (Chief Medical Officer at Alignment Healthcare, Inc.) reported an open-market sale of 32,479 shares of ALHC at an average $8.30, roughly $269,576, in a Form 4 filed 2026-10-07.

At post $8.55Now $7.00-18.1% since postedas of Nov 2, 4:15 PM ET

1d+1.9%

3d-11.8%

1w-3.7%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$ALHCr/ValueInvestingStock Analysisbullish

u/gamersEmpire · 28d agono track record yet

Can someone explain why ALHC is down this much?

ALHC appears undervalued with 30%+ revenue growth, 10% FCF yield, 13x forward PE, and $700M cash (44% of market cap). The metrics suggest the market is mispricing a growing healthcare company with strong fundamentals.

At post $8.50Now $7.00-17.6% since postedas of Nov 2, 4:15 PM ET

1d-1.5%

3d+2.5%

1w-4.8%

1m—

3m—

6m—

1y—

original post →

$ALHCSEC Form 4bearish

Maroney Dawn Christine · President at Alignment Healthcare, Inc. · 52d agono track record yet

Sold 122,707 @ $12.68 avg · $1,555,925 · 2026-09-11

Form 4: Maroney Dawn Christine sold ALHC

Maroney Dawn Christine (President at Alignment Healthcare, Inc.) reported an open-market sale of 122,707 shares of ALHC at an average $12.68, roughly $1,555,925, in a Form 4 filed 2026-09-11.

At post $12.61Now $7.00-44.5% since postedas of Nov 2, 4:15 PM ET

1d—

3d+2.6%

1w-33.8%

1m-40.2%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.